Huiru Zhang

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Weiding Wu · 5 shared papers, 2022–2024 · strength 0.91
   • Paper The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreati… DOI 10.1038/s41419-024-06589-7↗
   • Paper Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer. DOI 10.3389/fimmu.2022.956984↗
   • Paper Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. DOI 10.1002/ijc.34468↗
2. Long‐Yun Ye · 5 shared papers, 2022–2024 · strength 0.91
   • Paper The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreati… DOI 10.1038/s41419-024-06589-7↗
   • Paper Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer. DOI 10.3389/fimmu.2022.956984↗
   • Paper Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. DOI 10.1002/ijc.34468↗
3. Xianjun Yu · 5 shared papers, 2022–2024 · strength 0.91
   • Paper The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreati… DOI 10.1038/s41419-024-06589-7↗
   • Paper Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer. DOI 10.3389/fimmu.2022.956984↗
   • Paper Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. DOI 10.1002/ijc.34468↗
4. Kaizhou Jin · 5 shared papers, 2022–2024 · strength 0.91
   • Paper The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreati… DOI 10.1038/s41419-024-06589-7↗
   • Paper Neoadjuvant therapy alters the immune microenvironment in pancreatic cancer. DOI 10.3389/fimmu.2022.956984↗
   • Paper Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. DOI 10.1002/ijc.34468↗
5. Tianjiao Li · 4 shared papers, 2022–2024 · strength 0.70
   • Paper The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreati… DOI 10.1038/s41419-024-06589-7↗
   • Paper Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. DOI 10.1002/ijc.34468↗
   • Paper Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenoca… DOI 10.1016/j.canlet.2023.216411↗
6. Saimeng Shi · 3 shared papers, 2022–2023 · strength 0.46
   • Paper Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. DOI 10.1002/ijc.34468↗
   • Paper Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenoca… DOI 10.1016/j.canlet.2023.216411↗
   • Paper SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. DOI 10.1016/j.canlet.2022.01.026↗
7. Qinglin Fei · 3 shared papers, 2022–2023 · strength 0.46
   • Paper Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. DOI 10.1002/ijc.34468↗
   • Paper Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenoca… DOI 10.1016/j.canlet.2023.216411↗
   • Paper SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. DOI 10.1016/j.canlet.2022.01.026↗
8. Zhenyu Liao · 3 shared papers, 2022–2023 · strength 0.46
   • Paper Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. DOI 10.1002/ijc.34468↗
   • Paper Deubiquitinating PABPC1 by USP10 upregulates CLK2 translation to promote tumor progression in pancreatic ductal adenoca… DOI 10.1016/j.canlet.2023.216411↗
   • Paper SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. DOI 10.1016/j.canlet.2022.01.026↗
9. Xuan Lin · 2 shared papers, 2022–2023 · strength 0.30
   • Paper Tissue-resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. DOI 10.1002/ijc.34468↗
   • Paper SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. DOI 10.1016/j.canlet.2022.01.026↗
10. Chen Liu · 1 shared paper, 2024 · strength 0.24
    • Paper The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreati… DOI 10.1038/s41419-024-06589-7↗
11. Hao Li · 1 shared paper, 2022 · strength 0.13
    • Paper SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. DOI 10.1016/j.canlet.2022.01.026↗
12. Zhiwen Xiao · 1 shared paper, 2022 · strength 0.13
    • Paper SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. DOI 10.1016/j.canlet.2022.01.026↗
13. Huaxiang Xu · 1 shared paper, 2022 · strength 0.13
    • Paper SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. DOI 10.1016/j.canlet.2022.01.026↗
14. Liang Liu · 1 shared paper, 2022 · strength 0.13
    • Paper SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. DOI 10.1016/j.canlet.2022.01.026↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.